Stay updated on MGD024 Efficacy in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the MGD024 Efficacy in Hematologic Malignancies Clinical Trial page.

Latest updates to the MGD024 Efficacy in Hematologic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe webpage has updated a date from September 23, 2024, to May 1, 2025.SummaryDifference1.0%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to MGD024 Efficacy in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD024 Efficacy in Hematologic Malignancies Clinical Trial page.